Enzo Biochem, Inc., a public corporation listed on the New York stock exchange (ENZ) is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since our founding in 1976, our strategic focus has been on the development of enabling technologies in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies.The business activities of Enzo Biochem, Inc. are performed by the company‘s three wholly owned subsidiaries; Enzo Life Sciences, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc.